Clinical Trials

Study Title:
First-in-Human, Phase 1/1b, Open-label, Multicenter Study of Bifunctional EGFR/TGF; Fusion Protein BCA101 Alone and in Combination with Pembrolizumab in Patients with EGFR-Driven Advanced Solid Tumors

For more information about the trial above please contact the study team:

Principal Investigator, John Kaczmar, at kaczmar@musc.edu, or please call +1 843-792-6691.

Study Coordinator, Carly Fecio, at fecio@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina